Maternal factors involved in mother-to-child transmission of HIV-1

Journal of Acquired Immune Deficiency Syndromes

Volumn 5, Issue 10, 1992, Pages 1019-1029

  Rossi, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

HIV; HIV seroepidemiology; Maternal HIV transmission; Maternal immunity; Pediatric HIV infection; Pregnancy; Risk factors; Viral load

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BREAST FEEDING; CONFERENCE PAPER; FEMALE; FETUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; RISK FACTOR; SEROEPIDEMIOLOGY; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HIV-1; HUMAN; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SUPPORT, NON-U.S. GOV'T;

EID: 0026645958     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (129)

1. Chin J. Current and future dimensions of the HIV/AIDS pandemic in women and children. Lancet 1990; 336:221-4.
2. Global Program of AIDS. Current and future dimensions of the HIV/AIDS pandemic: a capsule summary, January 1992. Geneva: WHO/GPA/RES/SFI/92.1.
3. Hoff R, Berardi VP, Weiblen BJ, Mahoney-Trout L, Mitchell ML, Grady GF. Seroprevalence of human immunodeficiency virus among childbearing women. N Engl J Med 1988; 318:525-30.
4. Krasinski K, Borkowsky W, Bebenroth D, Moore T. Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population. N Engl J Med 1988; 318:185.
5. Novick LF, Berns D, Stricof R, Pass K, Wethers J. HIV seroprevalence in newborns in New York State. JAMA 1989; 261:1745-50.
6. Centers for Disease Control. National HIV seroprevalence surveys. MMWR 1989; 38:Sl-38.
7. Peckham CS, Tedder RS, Briggs M, et al. Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet 1990; 335:516-9.
8. McLaws M, Brown ARD, Cunningham PH, Imrie AA, Wilcken B, Cooper DA. Prevalence of maternal HIV infection based on anonymous testing of neonates, Sydney 1989. Med J Aust 1990; 153:383-6.
9. Ippolito G, Costa F, Stegagno M, Angeloni P, Angeloni U, Guzzanti E. Blind serosurvey of HIV antibodies in newborns in 92 Italian hospitals: a method for monitoring the infection rate in women at time of delivery. J Acquir Immune Defic Syndr 1991; 4:402-7.
10. Ades AE, Parker S, Berry T, et al. Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing. Lancet 1991:337:1562-5.
11. Tapin DM, Girdwood RWA, Follett EAC, Kennedy R, Brown AJ, Cockburn F Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet 1991:337:1565-7.
12. Caldwell MB, Rogers MF. Epidemiology of pediatric HIV infection. Pediatr Clin North Am 1991:38:1-16.
13. Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States: surveillance using newborn blood samples. JAMA 1991; 265:1704-8.
14. Barbacci M, Repke JT, Chaisson RE. Routine prenatal screening for HIV infection. Lancet 1991; 337:709-11.
15. Carswell JW, Lloyd G. Rise in prevalence of HIV antibodies recorded at an antenatal booking clinic in Kampala, Uganda. AIDS 1987; l:192-3.
16. Berkley S, Naamara W, Okware S, et al. AIDS and HIV infection in Uganda-are more women infected than men? AIDS 1990:4:1237-42.
17. Anderson RM, May RM, Boily MC, Garnett GP, Rowley JT The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS. Nature 1991:352:581-9.
18. Guay L, Mmiro F, Ndugwa C, et al. Perinatal outcome in HIV-infected women in Uganda. VI International Conference on AIDS, San Francisco, 1990, abstract ThC42.
19. Van de Perre P, Siminon A, Hitimana DG, et al. Mother to child transmission of HIV: first immunologic and serologic features from an ongoing cohort study in Kigali, Rwanda. VI International Conference on AIDS, San Francisco, 1990, abstract ThC43.
20. Scott G, Fischi MA, Klimas N, et al Mothers of infants with the acquired immunodeficiency syndrome: evidence for both symptomatic and asymptomatic carriers. JAMA 1985; 252:363-6.
21. Loche M, Mach B. Identification of HIV-infected seronegative individuals by a direct diagnostic test based on hybridisation to amplified viral DNA. Lancet 1988; 2:418-21.
22. European Collaborative Study. Mother-to-child transmission of HIV infection. Lancet 1988; 2:1039-42.
23. Italian Multicenter Study Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Lancet 1988; 2:1043-5.
24. Ryder RW, Nsa W, Hassig SE, et al Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1988; 320:1637-42.
25. Blanche S, Rouzioux C, Moscato M-LG, et al HIV Infection in Newborns French Collaborative Study Group. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989; 320:1643-8.
26. Selwyn PA, Schoenbaum EE, Davenny K, et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989; 261:1289-94.
27. Lallemant M, Lallemant-Le Coeur S, Cheynier D, et al. Mother to child transmission of HIV-1 and infant survival in Brazzaville, Congo. AIDS 1989; 3:643-6.
28. Goedert JJ, Mendez H, Drummond JE, et al Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gpl20. Lancet 1989; 2:1351-4.
29. Mok JYQ, Hague RA, Yap PL, et al. Vertical transmission of HIV: a prospective study. Arch Dis Child 1989; 64:1140-5.
30. Johnson JP, Nair P, Hines SE, et al. Natural history and serologie diagnosis of infants born to human immunodeficiency virus-infected women. Am J Dis Child 1989; 143:1147-53.
31. Rogers MF, Ou C-Y, Rayfield M, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. N Engl J Med 1989; 320:1649-54.
32. Hira SK, Kamanga J, Bhat GJ, et al. Perinatal transmission of HIV-1 in Zambia. Br Med J 1989:299:1250-2.
33. Andiman WA, Simpson J, Olson B, Dember L, Silva TJ, Miller G. Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short outcome of neonatal infection. Am J Dis Child 1990:144:758-66.
34. Halsey NA, Boulos R, Holt E, et al. CDS/JHU AIDS Project Team. Transmission of HIV-1 infections from mothers to infants in Haiti: impact on childhood mortality and malnutrition. JAMA 1990; 264:2088-92.
35. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991; 337:253-60.
36. Hutto C, Parks WP, Lai S, et al A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr 1991; 118:347-53.
37. Martin NL, Levy JA, Legg H, Weintrub PS, Cowan MJ, Wara DW. Detection of infection with human immunodeficiency virus (HIV) type 1 in infants by an anti-HIV immunoglobulin A assay using recombinant proteins. J Pediatr 1991; 118:354-8.
38. Scarlatti G, Lombardi V, Plebani A, et al Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children AIDS 1991; 5:1173-8.
39. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992; 339:1007-12.
40. Melchor JC, Gutierrez C, Larrieta R, Ariceta JM, Cor-costegui B Vertical transmission of HIV. J Acquir Immune Defic Syndr 1992; 5:529-30.
41. Perez Alvarez L, Gurbindo MD, Hernandez-Sampelayo T, et al. Mother-to-infant transmission of HIV and hepatitis C infections in children born to HIV-seropositive mothers. AIDS 1992, 6:427-40.
42. Morgan G, Wilkins HA, Pepin J, Jobe O, Brewster D, Whittle H. AIDS following mother-to-child transmission of HIV-2. AIDS 1990; 4:879-82.
43. Gayle HD, Gnaore, E, Adjorlolo G, et al. HIV-1 and HIV-2 infection in children in Abidjan, Cote d'Ivoire. J Acquir Immune Defìc Syndr 1992; 5:513-7.
44. Del Mistro A, Chotard J, Hall AJ, Whittle H, De Rossi A, Chieco-Bianchi L. HIV-1 and HIV-2 seroprevalence rates in mother-child pairs living in the Gambia (West Africa). J Acquir Immune Defic Syndr 1992; 5:19-24.
45. Poulsen A-G, Kvinesdal BB, Aaby P, et al. Lack of evidence of vertical transmission of human immunodeficiency virus type 2 in a sample of the general population in Bissau. J Acquir Immune Defic Syndr 1992; 5:25-30.
46. Falloon J, Eddy J, Weiner L, Pizzo PA Human immunodeficiency virus infection in children J Pediatr 1989; 114:1-30.
47. Pizzo PA. Pediatrie AIDS: problems within problems. J Infect Dis 1990; 161:316-25.
48. Scott GB. HIV infection in children: clinical features and management. J Acquir Immune Defic Syndr 1992; 5:109-15.
49. Wilfert CM. HIV infection in maternal and pediatric patients. Hosp Pract 1991; 0:55-67.
50. Sprecher S, Soumenkoff G, Puissant F, et al. Vertical transmission of HIV in a 15-week fetus. Lancet 1986; 2:288.
51. Jovaisas E, Koch MA, Schäfer A, et al. LAV/HTLVIII in 20-week fetus. Lancet 1985; 2:1129.
52. Lyman WD, Kress Y, Kure K, Rashbaum WK, Rubinstein A, Soeiro R. Detection of HIV in fetal central nervous system tissue. AIDS 1990; 4:917-20.
53. Corgnaud V, Laure F, Broussard A, et al. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retrovir 1991; 7:337-41.
54. Ehrnst A, Lindgren S, Dictor M, et al HIV in pregnant women and their offspring: evidence for late transmission Lancet 1991; 338:203-7.
55. Soeiro R, Rubinstein A, Rashbaum WK, Lyman WD. Maternofetal transmission of AIDS: frequency of HIV-1 nucleic acid sequences in human fetal DNA. J Infect Dis (in press).
56. Viscarello RR. In utero detection of human immunodeficiency virus infection: preliminary studies. Arch AIDS Res 1990; 4:245-59.
57. Cullen MT, Viscarello RR, Paryani S, Sanchez-Ramos L. Prenatal diagnosis of HIV infection: the use of cordocentesis, polymerase chain reaction, and p24 antigen assay [Abstract]. Am J Obstet Gynecol 1992; 166.
58. Viscarello RR, DeGennaro Griffith SM, Andiman W, Hob-bins JC. Does an antepartum invasive procedure increase the risk of perinatal transmission of HIV-1 [Abstract]? Am J Obstet Gynecol 1992; 166.
59. Viscarello RR, Hobbins JC. The presence of human immunodeficiency virus p24 antigen in amniotic fluid as a clinical marker for postpartum disease progression [Abstract]. Am J Obstet Gynecol 1990; 166.
60. Viscarello RR, Cullen MT, DeGennaro NJ, Hobbins JC. Fetal blood sampling in human immunodeficiency viruspositive omen prior to elective, mid-trimester termination of pregnancy [Abstract]. Am J Obstet Gynecol 1992; 166.
61. Jones DS, Byers RH, Bush TJ, Oxtoby MJ, Rogers MF. Epidemiology of transfusion-associated acquired immunodeficiency syndrome in children in the United States, 1981 through 1989. Pediatrics 1992, 89:123-7.
62. Goedert JJ, Duliege A-M, Amos CI, Felton S, Biggar RJ International registry of HIV-exposed twins Lancet 1991; 338:1471-5.
63. Chiodo F, Ricci E, Costigliola P, Michelacci L, Bovicelli L, Dallascasa P. Vertical transmission of HTLV-III. Lancet 1986, 1:739.
64. Mok JQ, Gianquinto C, DeRossi A, Grosch-Worner I, Ades AE, Peckham CS. Infants born from mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study. Lancet 1987; 1:1164-8.
65. Lindgren S, Anzen B, Bohlin A-B, Lindman K HIV and child-bearing: clinical outcome and aspects of mother-to infant transmission AIDS 1991; 5:1111-6.
66. Gabiano C, Tovo P-A, deMartino M, Galli L. Italian Multicenter Study. HIV-1 transmission rate in first born children to seropositive mothers and interfering factors [Abstract WC3241]. Vllth International Conference on AIDS, San Francisco, 1991:356.
67. Marion RW, Wiznia AA, Hutcheon G, Rubinstein A Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. Am J Dis Child 1986; 140:638-40.
68. Iosub S, Bamjii M, Stone RK, Gromisch DS, Wasserman E. More on human immunodeficiency virus embryopathy. Pediatrics 1987; 80:512-6.
69. Perro M. Dysmorphism leading to a diagnosis of acquired immunodeficiency syndrome. Am J Dis Child 1987; 141:474.
70. Qazi QH, Sheikh TM, Fikrig S, Menikoff H Lack of evidence for craniofacial dysmorphism in perinatal human immunodeficiency virus infection. J Pediatr 1988; 112:7-11.
71. Nicholas SW. Controversy: is there an HIV-associated facial dysmorphism? Pediatr Annu 1988; 17:353-61.
72. Embree JE, Braddick M, Datta P, et al. Lack of correlation of maternal human immunodeficiency virus infection with neonatal malformations. Pediatr Infect Dis J 1989; 8:700-4.
73. Krivine A, Firtion G, Cao L, Francoual C, Henrion R, Lebon P. HIV replication during the first weeks of life. 1992; 330:1187-9.
74. Bryson Y, Chen I, Miles S, et al. A prospective evaluation of HIV co-culture for early diagnosis of perinatal HIV infection. VII International Conference on AIDS, Florence, 1991, abstract book 2:185, abstract WB2014.
75. Thiry L, Sprecher-Goldberger S, Jonckeneer T, et al Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 1985; 2:891-2.
76. Zeigler JB, Cooper DA, Johnson RO, Gold J Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985; 2:896-8.
77. Bucens M, Armstrong J, Stuckey M. Virological and electron microscopic evidence for postnatal HIV transmission via breast mile. IV International Conference on AIDS. Stockholm, 1988, book 1, 339, abstract 5099.
78. Yolken R, Ruff A, Miotti P, et al. Measurement of HIV antibodies and nucleic acids in human milk [Abstract 1655]. Pediatr Res 1990; 27:279A.
79. Colebunders RL, Kapita B, Nekwei W, et al. Breastfeeding and transmission of HIV. Lancet 1988; 2:1487.
80. Weinbreck P, Loustand V, Denis F, et al. Postnatal transmission of HIV infection. Lancet 1988; 2:482.
81. Hira SK, Mangrola UG, Mwale C, et al Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia J Pediatr 1990, 117:421-4.
82. Stiehm ER, Vink P. Transmission of human immunodeficiency virus by breastfeeding. J Pediatr 1991; 118:410-2.
83. Ryder RW, Manzila T, Baende E, et al. Evidence from Zaire that breastfeeding by HIV-1 seropositive mothers is not a major route for perinatal HIV-1 transmission but does decrease morbidity. AIDS 1991; 5:709-14.
84. Belec L, Bouquety J-C, Georges AJ, Siopathis MR, Martin PMV Antibodies to human immunodeficiency virus in the breast milk of healthy seropositive women. Pediatrics 1990; 85:1022-6.
85. Oxtoby MJ. Human immunodeficiency virus and other viruses in human milk: placing the issues in a broader perspective. Pediatr Infect Dis J 1988, 7:825-35.
86. Lederman SA. Estimating infant mortality from human immunodeficiency virus and other causes in breast-feeding and bottle-feeding populations. Pediatrics 1992; 89:290-6.
87. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322:166-72.
88. Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992; 165:352-63.
89. d’ Arminio Montforte A, Ravizza M, Muggiasca ML, et al. HIV infected pregnant women: possible predictors of vertical transmission. VII International Conference on AIDS, Florence, 1991, abstract book 2:35, abstract W.C.49.
90. Hague RA, Mok JYQ, MacCallum L, Burns S, Yap PL. Do maternal factors influence the risk of vertical transmission of HIV? VII International Conference on AIDS, Florence, 1991, abstract book 2:355, abstract W.C.3237.
91. St. Louis ME, Kabagabo U, Brown C, et al. Maternal factors associated with perinatal HIV transmission. VII International Conference on AIDS, Florence, 1991, abstract book 1:304, abstract W.C.3027.
92. Tibaldi C, Palomba E, Ziarati N, Sciandra M, Gabiano C, Sinicco A. Maternal factors influencing vertical HIV transmission. VII International Conference on AIDS, Florence, 1991, abstract book 2:365, abstract W.C.3277.
93. Datta P, Embree J, Ndinya-Achola JO, Kreiss J, Plummer FA. Perinatal transmission in Nairobi, Kenya: 5 year follow-up. VII International Conference on AIDS, Florence, 1991, abstract book 1:20, abstract M.C.3.
94. Lange JMA, Paul DA, Huisman HG, et al. Persistent HIV antigenemia and decline in HIV core antibodies associated with transition to AIDS. Br Med J 1986; 293:1459-62.
95. Mathez D, Paul D, de Belilovsky C, et al. Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient. Proc Natl Acad Sci USA 1990; 87:7438-42.
96. Phillips AN, Lee CA, Elford J, et al. p24 antigenemia, CD4 lymphocyte counts and the development of AIDS. AIDS 1991; 5:1217-22.
97. Devash Y, Calvelli TA, Wood DG, et al. Vertical transmission of human immunodeficiency virus is correlated with the absence of high affinity/avidity maternal antibodies to the gpl20 principal neutralizing domain. Proc Natl Acad Sci USA 1990; 87:3445-9.
98. Boue F, Pons JC, Keros L, et al. Risks for HIV 1 perinatal transmission vary with the mother's stage of HIV infection. VI International Conference on AIDS, San Francisco, 1990, abstract book pl44, abstract Th.C.44.
99. Tovo PA, et al. Br J Obstet Gynaecol 1991.
100. Johnson JP, Vink PE, Hines SE, et al Vertical transmission of human immunodeficiency virus from seronegative of indeterminate mothers. Am J Dis Child 1991; 145:1239-41.
101. M-Fontelos P, Mellado MJ, Villota J, et al. Evolution of a series of pediatrie AIDS related to different strains of HIV. VII International Conference on AIDS, Florence, 1991, abstract book 2:189, abstract 33 W.B.2030.
102. Wolinsky SM, Wike CM, Korber BTM, et al Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992; 255:1134-7.
103. Kreiss J, Datta P, Willerford D, et al. Vertical transmission of HIV in Nairobi: correlation with maternal viral burden. VII International Conference on AIDS, Florence, 1991, abstract book 1:313, abstract M.C.3062.
104. Goudsmit J. Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts. AIDS 1988; 2:S41-5.
105. Ljunggren K, Moschese V, Broliden P-A, et al. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J Infect Dis 1990; 161:198-202.
106. Van de Perre P, Lepage P, Simonon A, et al. Biological markers associated with prolonged survival in African children maternally infected by the human immunodeficiency virus type 1. AIDS Res Hum Retrovir 1992; 8:435-41.
107. Brenner TJ, Dahl KE, Olson B, Miller G, Andiman WA. Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children. Lancet 1991; 337:1001-5.
108. Rossi P, Moschese V, Broliden PA, et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gpl20 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Nati Acad Sci USA 1989; 86:8055-8.
109. Rossi P, Moschese V, Wigzell H, et al Mother-to-infant transmission of HIV. Lancet 1990; 335:359-60.
110. Parekh BS, Shaffer N, Pau C-P, et al. Lack of correlation between maternal antibodies to V3 loop peptides of gpl20 and perinatal HIV-1 transmission. AIDS 1991; 5:1179-84.
111. Halsey NA, Markham R, Wahren B, et al. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission. J Acquir Immune De fic Syndr 1992; 5:153-7.
112. Allain JP, Matthews T, Coombs R, et al. Antibody to V3 loop does not predict vertical transmission of HIV. VII International Conference on AIDS, Florence, 1991, abstract book 2, abstract W.C.2263.
113. Malanda N, St. Louis M, George JR, et al. Low prevalence in HIV-infected Zairian mothers of antibodies against gp 120 neutralizing epitopes of the MN HIV-1 isolate and lack of association with perinatal HIV transmission. VII International Conference on AIDS, Florence, 1991, abstract book 1:314, abstract M.C.3065.
114. Ugen KE, Goedert JJ, Boyer J. Vertical transmission of HIV infection: reactivity of maternal sera with gp 120 and gp41 peptides from HIV-1. J Clin Invest (in press).
115. Connor E, Bardequez A, Apuzzio J. The interpartum management of the HIV-infected mother and her infant. Clin Perinatol 1989; 16:899-908.
116. Berrebi A, Chraibi J, Kobuch WE, et al. Influence of pregnancy on HIV disease. VII International Conference on AIDS, Florence, 1991, abstract book 2:193, abstract W.B.2046.
117. Di Lenardo L, Truscia D, Gianquinto C, Grella PV. A prospective study of HIV in pregnant women. V International Conference on AIDS, Montreal, 1989:224, abstract M.B.P.14.
118. Biggar RJ, Pahwa S, Minkoff H, et al. Immunosuppression in pregnant women infected with human immunodeficiency virus. Am J Obstet Gynecol 1989; 161:1239-44.
119. Nzila N, Laga M, Brown C, et al. Does pregnancy in HIV(+) women accelerate to AIDS? VII International Conference on AIDS, Florence, 1991, abstract book 1:335, abstract M.C.3149.
120. Deschamps M-M, Pape JW, Madhaven S, Johnson WD Jr. Pregnancy and acceleration of HIV-related illness. V International Conference on AIDS, Montreal, 1989:222, abstract M.B.P.6.
121. Delfraissy JF, Pons JC, Sereni D, et al. Does pregnancy influence disease progression in HIV positive women? V International Conference on AIDS, Montreal, 1989:227, abstract M.B.P.34.
122. Williams LM, Cloyd MW Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates Virology 1991; 184:723-8
123. Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA. HIV-1 in trophoblastic and villous Hofbauer cells, and hematologic precursors in eight week fetuses. Lancet 1990; 335:565-0.
124. Maury W, Potts BJ, Rabson AB. HIV-1 infection of firsttrimester and term human placental tissue: a possible mode of maternal-fetal transmission. J Infect Dis 1989; 160:583-8.
125. Amirhessami-Aghila N, Spector SA Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection J Virol 1991; 65:2231-6
126. Chandwani S, Greco MA, Mittal K, Antoine C, Krasinski K, Borkowsky W Pathology and human immunodeficiency virus expression placentas of seropositive women. J Infect Dis 1991; 1163:1134-8.
127. Jimenes E, Unger E, Eitelbach F, et al. Demonstration of HIV antigens in birth placentae and therapeutic abortions. Placenta 1989; 10:453-527.
128. Brady K, Martin A, Page D, Purdy S, Neiman RS. Localization of human immunodeficiency virus in placental tissue. Lab Invest 1989; 60:69A.
129. Mattern CFT, Murray K, Jensen A, Farzadegan H, Pang J, Modlin JF Localization of human immunodeficiency virus core antigen in term placentas Pediatrics 1992; 89:207-9.